Press Release Innovent Presents Updated Data From Innovative Anti-CLDN18.2 ADC (IBI343) Phase 1 Study in Patients with Advanced Pancreatic Cancer at the ESMO Asia Congress 2024 9 December 2024
Press Release AbbVie Announces Emotional Impact Report on Mental Health of Underrepresented CLL Cancer Patients 9 December 2024
Press Release Apple Sued for Knowingly Hosting Child Sexual Abuse Material on Its Products, Failing to Protect Survivors 9 December 2024
Press Release Powering Canada’s Future: Ensuring Access to Affordable, Reliable and Clean Electricity in New Brunswick 9 December 2024
Press Release DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) shows 51 percent reduction in risk of progression to active multiple myeloma for patients with high-risk smoldering multiple myeloma 9 December 2024
Press Release Riyadh Action Agenda Gathers Steam as Land Governance Takes Center Stage at UNCCD COP16 9 December 2024
Press Release Syndax Presents Positive Revuforj® (revumenib) Data in Acute Leukemias from Multiple Trials, Including the SAVE Combination and AUGMENT-101 Trials, at 66th ASH Annual Meeting 9 December 2024
Press Release Blueprint Medicines’ Continued Leadership in Redefining the Standard of Care in Systemic Mastocytosis Highlighted at 2024 ASH Annual Meeting 9 December 2024
Press Release Nektar Therapeutics Announces NKTR-255 Following CD19-directed CAR-T Therapy Enhanced Complete Response Rates in Patients with Relapsed or Refractory Large B-cell Lymphoma at the 66th Annual ASH Meeting 9 December 2024
Press Release Researchers Report New Opportunities to Improve Quality of Life for People with Non-Malignant Blood Disorders 9 December 2024
